Evaluation of WHO criteria for viral failure in patients on antiretroviral treatment in resource-limited settings

AIDS Research and Treatment

Volumn 2011, Issue , 2011, Pages

  Castelnuovo, Barbara ^a   Sempa, Joseph ^a   Agnes, Kiragga N ^a   Kamya, Moses R ^a   Manabe, Yukari C ^a,b  

^a MAKERERE UNIVERSITY   (Uganda)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868298059     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2011/736938     Document Type: Article

References (20)

1. Sklar P. A., Ward D. J., Baker R. K., Wood K. C., Gafoor Z., Alzola C. F., Moorman A. C., Holmberg S. D., Tong T., Palella F. J., Chmiel J. S., Kalnins A., Lichtenstein K. A., Greenberg K. S., Young B., Widick B., Stewart C., Zellner P., Yangco B. G., Halkias K., Lapierre C., Owen C. A., Fuhrer J., Ording-Bauer L., Kelly R., Esteves J., Tedaldi E. M., Walker-Kornegay L., Marzouk J. B., Phelps R. T., Rachel M., McCabe R. E., Rachel M., Prevalence and clinical correlates of HIV viremia ('blips') in patients with previous suppression below the limits of quantification. AIDS 2002 16 15 2035 2041 2-s2.0-0037131203 10.1097/00002030-200210180-00008 (Pubitemid 35205267)
2. Di Mascio M., Markowitz M., Louie M., Hogan C., Hurley A., Chung C., Ho D. D., Perelson A. S., Viral blip dynamics during highly active antiretroviral therapy. Journal of Virology 2003 77 22 12165 12172 2-s2.0-0242300180 10.1128/JVI.77.22.12165-12172.2003 (Pubitemid 37339869)
3. Greub G., Cozzi-Lepri A., Ledergerber B., Staszewski S., Perrin L., Miller V., Francioli P., Furrer H., Battegay M., Vernazza P., Bernasconi E., Günthard H. F., Hirschel B., Phillips A. N., Telenti A., Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy. AIDS 2002 16 14 1967 1969 2-s2.0-0037183958 10.1097/00002030-200209270-00017
4. Easterbrook P. J., Ives N., Waters A., Mullen J., O'Shea S., Peters B., Gazzard B. G., The natural history and clinical significance of intermittent viraemia in patients with initial viral suppression to 400 copies/ml. AIDS 2002 16 11 1521 1527 2-s2.0-0037178326 10.1097/00002030-200207260-00009 (Pubitemid 34804217)
5. Van Sighem A., Zhang S., Reiss P., Gras L., Van Der Ende M., Kroon F., Prins J., De Wolf F., Immunologic, virologic, and clinical consequences of episodes of transient viremia during suppressive combination antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 2008 48 1 104 108 2-s2.0-42649135133 10.1097/QAI.0b013e31816a1d4f (Pubitemid 351600855)
6. Cozzi-Lepri A., Phillips A. N., Miller V., Katlama C., Ledergerber B., Vella S., Weber J., Bruun J. N., Kirk O., Clotet B., Lundgren J. D., Changes in viral load in people with virological failure who remain on the same HAART regimen. Antiviral Therapy 2003 8 2 127 136 2-s2.0-0037692997 (Pubitemid 36565893)
7. Murri R., Lepri A. C., Cicconi P., Poggio A., Arlotti M., Tositti G., Santoro D., Soranzo M. L., Rizzardini G., Colangeli V., Montroni M., Monforte A. D., Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian Cohort of Antiretroviral-Naive patients study. Journal of Acquired Immune Deficiency Syndromes 2006 41 1 23 30 2-s2.0-28944437070 10.1097/01.qai.0000188337.76164.7a (Pubitemid 41786015)
8. WHO, Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach. 2006, http://www.who.int/hiv/pub/ guidelines/art/en/index.html
9. WHO, Antiretroviral therapy for HIV infection in adults and adolescents. 2009, http://www.who.int/hiv/pub/arv/rapid-advice-art.pdf
10. Kamya M. R., Mayanja-Kizza H., Kambugu A., Bakeera-Kitaka S., Semitala F., Mwebaze-Songa P., Castelnuovo B., Schaefer P., Spacek L. A., Gasasira A. F., Katabira E., Colebunders R., Quinn T. C., Ronald A., Thomas D. L., Kekitiinwa A., Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 2007 46 2 187 193 2-s2.0-34748846895 10.1097/QAI.0b013e31814278c0 (Pubitemid 47482614)
11. Castelnuovo B., Manabe Y., Kiragga A., Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first three years after antiretroviral therapy in an urban African cohort. Clinical Infectious Diseases 2009 49 965 972
12. Mackie N. E., nicola.mackie@imperial.nhs.uk Phillips A. N., Kaye S., Booth C., Geretti A.-M., Antiretroviral drug resistance in HIV-1-infected patients with low-level viremia. Journal of Infectious Diseases 2010 201 9 1303 1307 10.1086/651618
13. Mee P., Fielding K. L., Charalambous S., Churchyard G. J., Grant A. D., Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. AIDS 2008 22 15 1971 1977 2-s2.0-53549099373 10.1097/QAD.0b013e32830e4cd8
14. Moore D. M., Awor A., Downing R., Kaplan J., Montaner J. S. G., Hancock J., Were W., Mermin J., CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologie failure receiving antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 2008 49 5 477 484 2-s2.0-62749083727 10.1097/QAI.0b013e318186eb18
15. Hosseinipour M. C., Van Oosterhout J. J. G., Weigel R., Phiri S., Kamwendo D., Parkin N., Fiscus S. A., Nelson J. A. E., Eron J. J., Kumwenda J., The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. AIDS 2009 23 9 1127 1134 2-s2.0-67650395240 10.1097/QAD.0b013e32832ac34e
16. Reynoids S. J., Nakigozi G., Newell K., Ndyanabo A., Galiwongo R., Boaz I., Quinn T. C., Gray R., Wawer M., Serwadda D., Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda. AIDS 2009 23 6 697 700 2-s2.0-64549102559 10.1097/QAD.0b013e3283262a78
17. Kantor R., Diero L., Delong A., Kamle L., Muyonga S., Mambo F., Walumbe E., Emonyi W., Chan P., Carter J. E., Hogan J., Buziba N., Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings. Clinical Infectious Diseases 2009 49 3 454 462 2-s2.0-67651085129 10.1086/600396
18. Castelnuovo B., bcastelnuovo@idi.co.ug Kiragga A., Schaefer P., Kambugu A., Manabe Y., High rate of misclassification of treatment failure based on WHO immunological criteria. AIDS 2009 23 10 1295 1296 10.1097/QAD.0b013e32832cbd43
19. Coetzee D., Boulle A., Hildebrand K., Asselman V., Van Cutsem G., Goemaere E., Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS 2004 18 3, supplement S27 S31 2-s2.0-3843140514 10.1097/00002030-200406003-00006
20. Long L., Fox M., Sanne I., Rosen S., The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa. AIDS 2010 24 6 915 919 2-s2.0-77949542978 10.1097/QAD.0b013e3283360976